127 related articles for article (PubMed ID: 29198127)
1. Immunohistochemical investigation of P16, P53 and Ki-67's prognostic values in diffuse large B-Cell lymphomas.
Baran M; Canoz O; Altuntas H; Sivgin S; Cetin M; Yay A; Ketenci S
Bratisl Lek Listy; 2017; 118(10):602-608. PubMed ID: 29198127
[TBL] [Abstract][Full Text] [Related]
2. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL
Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic implications of cell cycle regulatory molecules, p16, p21, p27, p14 and p53 in germinal centre and non-germinal centre B-like diffuse large B-cell lymphomas.
Paik JH; Jeon YK; Park SS; Kim YA; Kim JE; Huh J; Lee SS; Kim WH; Kim CW
Histopathology; 2005 Sep; 47(3):281-91. PubMed ID: 16115229
[TBL] [Abstract][Full Text] [Related]
4. Expression of p16, p53, and Ki-67 in colorectal adenocarcinoma: a study of 356 surgically resected cases.
Huh JW; Lee JH; Kim HR
Hepatogastroenterology; 2010; 57(101):734-40. PubMed ID: 21033219
[TBL] [Abstract][Full Text] [Related]
5. Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas.
Zhang A; Ohshima K; Sato K; Kanda M; Suzumiya J; Shimazaki K; Kawasaki C; Kikuchi M
Pathol Int; 1999 Dec; 49(12):1043-52. PubMed ID: 10632924
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma.
Llanos M; Alvarez-Argüelles H; Alemán R; Oramas J; Diaz-Flores L; Batista N
Med Oncol; 2001; 18(1):15-22. PubMed ID: 11778965
[TBL] [Abstract][Full Text] [Related]
7. Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas.
Bai M; Vlachonikolis J; Agnantis NJ; Tsanou E; Dimou S; Nicolaides C; Stefanaki S; Pavlidis N; Kanavaros P
Mod Pathol; 2001 Nov; 14(11):1105-13. PubMed ID: 11706071
[TBL] [Abstract][Full Text] [Related]
8. [Factors affecting the prognosis of diffuse large B-cell lymphoma in Chinese].
Weng Y; Gao ZF; Liu K; Zhang WJ; Ke XY; Li M
Zhonghua Nei Ke Za Zhi; 2005 Sep; 44(9):681-3. PubMed ID: 16202261
[TBL] [Abstract][Full Text] [Related]
9. A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients.
Abdulla M; Laszlo S; Triumf J; Hedström G; Berglund M; Enblad G; Amini RM
Acta Oncol; 2016; 55(9-10):1126-1131. PubMed ID: 27549735
[TBL] [Abstract][Full Text] [Related]
10. Distinctive immunohistochemical profile of penile intraepithelial lesions: a study of 74 cases.
Chaux A; Pfannl R; Rodríguez IM; Barreto JE; Velazquez EF; Lezcano C; Piris A; Netto GJ; Cubilla AL
Am J Surg Pathol; 2011 Apr; 35(4):553-62. PubMed ID: 21399489
[TBL] [Abstract][Full Text] [Related]
11. Alterations of the p53, Rb and p27 tumor suppressor pathways in diffuse large B-cell lymphomas.
Bai M; Tsanou E; Skyrlas A; Sainis I; Agnantis N; Kanavaros P
Anticancer Res; 2007; 27(4B):2345-52. PubMed ID: 17695524
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of MIB-1 and p53 overexpression as risk factors in large cell non-Hodgkin lymphoma in adults.
El-Bolkainy TN; El-Bolkainy MN; Khaled HM; Mokhtar NM; Eissa SS; Gouda HM; El-Hattab OH
J Egypt Natl Canc Inst; 2007 Dec; 19(4):231-8. PubMed ID: 19672286
[TBL] [Abstract][Full Text] [Related]
13. [Expression and prognostic value of COX- 2, p16(INK4A) and p53 in patients with classical Hodgkin lymphoma].
Shi Y; Gao Z; Liu C; Huang X; Song Y; Ping L; Zhou L; Zhao M; Huang X; Lai Y; Du T; Li M
Zhonghua Xue Ye Xue Za Zhi; 2015 Nov; 36(11):926-32. PubMed ID: 26632465
[TBL] [Abstract][Full Text] [Related]
14. [Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma].
Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Song YW; Sun Y; Shi YK
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):456-461. PubMed ID: 29936773
[No Abstract] [Full Text] [Related]
15. Expression of regulatory proteins and proliferative activity in relation to phenotypic characteristics of upper urothelial carcinoma.
Dolićanin Z; Velicković LJ; Djordjević B; Visnjić M; Pesić I; Ristić A; Marjanović V
Vojnosanit Pregl; 2011 Jul; 68(7):567-74. PubMed ID: 21899177
[TBL] [Abstract][Full Text] [Related]
16. p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function.
Xu-Monette ZY; Zhang S; Li X; Manyam GC; Wang XX; Xia Y; Visco C; Tzankov A; Zhang L; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhao X; Møller MB; Parsons BM; Winter JN; Piris MA; Medeiros LJ; Young KH
Aging (Albany NY); 2016 Feb; 8(2):345-65. PubMed ID: 26878872
[TBL] [Abstract][Full Text] [Related]
17. A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution.
Huang JJ; Xia Y; Wang Y; Liu PP; Bi XW; Sun P; Lin TY; Jiang WQ; Li ZM
Oncotarget; 2016 Jul; 7(27):41242-41250. PubMed ID: 27183909
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53, p21WAF1/CIP1, p16INK4A and Ki-67 proteins in serous ovarian tumors.
Buchynska LG; Nesina IP; Yurchenko NP; Bilyk OO; Grinkevych VN; Svintitsky VS
Exp Oncol; 2007 Mar; 29(1):49-53. PubMed ID: 17431389
[TBL] [Abstract][Full Text] [Related]
19. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
Kim LH; Peh SC; Poppema S
Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
[TBL] [Abstract][Full Text] [Related]
20. [Ki-67 proliferative index in non-Hodgkin's lymphoma and its clinical significance].
Li J; Hu R; Liao AJ; Shi HY; Yan W; Liu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):935-9. PubMed ID: 21867618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
